"Le Centre Hospitalier d'Antibes Juan-les-Pins propose une offre de soins diversifiée et modernisée. L'hôpital assure les examens de diagnostic, la surveillance et le traitement des patients en médecine, chirurgie, obstétrique, pédiatrie, psychiatrie, gériatrie, et l'aide médicale d'urgence. Le Centre Hospitalier dispose de 704 lits/places. Sa communauté se compose de plus de 200 médecins et de plus de 1000 personnels non médicaux. L'établissement public de santé s'adresse aux habitants de la CASA (Communauté d’Agglomération de Sophia Antipolis) (Biot, Cagnes-sur-Mer, Saint-Laurent-du-Var, Valbonne, Vallauris, Vence, Vallauris, Vence, Villeneuve-Loubet) ainsi qu'aux nombreux touristes qui y séjournent."

During the past decade, CH Antibes conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Antibes" #1 sponsor was "Centre Hospitalier Universitaire de Nice" with 3 trials, followed by "The Lymphoma Academic Research Organisation" with 3 trials sponsored, "ResMed" with 2 trials sponsored, "Biotronik AG" with 1 trials sponsored and "Biotronik France" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Antibes" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Biosensors Europe SA" with 1 trials as a collaborator and "Biotronik France" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "CH Antibes" are "Coronary Artery Disease" (2 trials), "Acute Myocardial Infarction" (1 trials), "Bradycardia" (1 trials), "Breast Cancer" (1 trials) and "COVID" (1 trials). Many other conditions were trialed in "CH Antibes" in a lesser frequency.

Most popular intervention types in "CH Antibes" are "Drug" (7 trials), "Device" (5 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASV Treatment" (1 trials), "Adaptative Servo Ventilation" (1 trials), "BEACOPPesc" (1 trials), "BEACOPPesc - ABVD - PET2" (1 trials) and "Conventional technique" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Antibes" are 17 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CH Antibes". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in CH Antibes, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CH Antibes, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".